Open Access

Selection of non-small cell lung cancer patients for intercalated chemotherapy and tyrosine kinase inhibitors

Matjaz Zwitter

Matjaz Zwitter

  • Institute of Oncology LjubljanaLjubljana, Slovenia
  • Faculty of Medicine, University of MariborMaribor, Slovenia
Search for this author on
Sciendo|Google Scholar
Zwitter, Matjaz
, 
Antonio Rossi

Antonio Rossi

Division of Medical Oncology, IRCCS Casa Sollievo della Sofferenza HospitalSan Giovanni Rotondo (FG), Italy
Search for this author on
Sciendo|Google Scholar
Rossi, Antonio
, 
Massimo Di Maio

Massimo Di Maio

Division of Medical Oncology, Mauriziano Hospital, Oncology Department, University of TurinTorino, Italy
Search for this author on
Sciendo|Google Scholar
Di Maio, Massimo
, 
Maja Pohar Perme

Maja Pohar Perme

Institute for Biostatistics and Medical Informatics, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Search for this author on
Sciendo|Google Scholar
Perme, Maja Pohar
 and 
Gilberto Lopes

Gilberto Lopes

Centro Paulista de Oncologia e HCor Onco, members of the Oncoclinicas do Brasil Group, Sao Paulo, Brazil and Sylvester Comprehensive Cancer Center, University of MiamiMiami, FL, USA
Search for this author on
Sciendo|Google Scholar
Lopes, Gilberto
  
Jul 18, 2017
Selection of non-small cell lung cancer patients for intercalated chemotherapy and tyrosine kinase inhibitors's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Article Category: Review
Published Online: Jul 18, 2017
Page range: 241 - 251
Received: May 03, 2017
Accepted: Jun 09, 2017
DOI: https://doi.org/10.1515/raon-2017-0029
Keywords
© 2017 Matjaz Zwitter, Antonio Rossi, Massimo Di Maio, Maja Pohar Perme, Gilberto Lopes
This work is licensed under the Creative Commons Attribution 4.0 International License.
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, Internal Medicine, Haematology, Oncology, Radiology
Journal RSS Feed